Osteoarthritis Knee Pain (ATB-346-P2B-DRF)

A double-blind, placebo-controlled, 4-arm, Phase 2B study to asses the efficacy and safety of a 14-Day dosing regimen of 3 doses of ATB-346 versus Placebo, orally administered once daily to male and female patients diagnosed with Osteoarthritis of the Knee.

Register Today!

Trial Information

Start DateDecember 2019
End DateJan/Feb 2020
Trial Duration2 Months
Number of Visits6
Lead CRCMarija Bernstein

For additional information on this trial contact: